Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients | BMC Cancer | Full Text

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients | BMC Cancer | Full Text

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients

Anti-Androgen Receptor (AR) therapy holds promise for a subset of AR expressing triple-negative breast cancer (TNBC) patients. However, current AR assays are suboptimal in detecting the dynamic range of AR exp...

Authors:Sindhu Govindan, Mallikarjuna Siraganahalli Eswaraiah, Chetana Basavaraj, Manjula Adinarayan, Satish Sankaran and Manjiri Bakre

Citation:BMC Cancer 2020 20:745

Content type:Research article

 

Published on: 10 August 2020

• ViewFull Text
 
• ViewPDF